Home » Stocks » CNTX

Context Therapeutics, Inc. (CNTX)

Context Therapeutics will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet
Market Cap n/a
Revenue (ttm) n/a
Net Income (ttm) 4.93M
Shares Out n/a
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day n/a
Last Price n/a
Previous Close n/a
Change ($) n/a
Change (%) n/a
Day's Open n/a
Day's Range n/a
Day's Volume n/a
52-Week Range n/a

News

Context Therapeutics, Inc. has filed to go public with an IPO on the NASDAQ.

3 weeks ago - SEC

About CNTX

Context Therapeutics® is a clinical-stage biopharmaceutical company dedicated to improving the lives of women living with cancer. Our development team is advancing a pipeline of innovative therapies with a primary focus on treating female cancers, which include, but are not limited to, breast, ovarian and endometrial cancer. Our first program and lead product candidate, onapristone extended release (“ONA-XR”), builds upon a foundation of successful drug development by our management team and advisors in the field of female hormone-dependen... [Read more...]

Industry
Pharmaceutical Preparations
IPO Date
Pending
CEO
Martin Lehr
Employees
2
Stock Exchange
NASDAQ
Ticker Symbol
CNTX
Full Company Profile

Financial Performance

Financial Statements